Cargando…
Engineering probiotics to inhibit Clostridioides difficile infection by dynamic regulation of intestinal metabolism
Clostridioides difficile infection (CDI) results in significant morbidity and mortality in hospitalised patients. The pathogenesis of CDI is intrinsically related to the ability of C. difficile to shuffle between active vegetative cells and dormant endospores through the processes of germination and...
Autores principales: | Koh, Elvin, Hwang, In Young, Lee, Hui Ling, De Sotto, Ryan, Lee, Jonathan Wei Jie, Lee, Yung Seng, March, John C., Chang, Matthew Wook |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9253155/ https://www.ncbi.nlm.nih.gov/pubmed/35787625 http://dx.doi.org/10.1038/s41467-022-31334-z |
Ejemplares similares
-
Engineered probiotic Escherichia coli can eliminate and prevent Pseudomonas aeruginosa gut infection in animal models
por: Hwang, In Young, et al.
Publicado: (2017) -
Consortium of Probiotics Attenuates Colonization of Clostridioides difficile
por: Li, Xianping, et al.
Publicado: (2019) -
An Engineered
Probiotic Produces a Type III Interferon
IFNL1 and Reduces Inflammations in in vitro Inflammatory
Bowel Disease Models
por: Chua, Koon Jiew, et al.
Publicado: (2022) -
In Vitro and In Vivo Anti-Clostridioides difficile Effect of a Probiotic Bacillus amyloliquefaciens Strain
por: Islam, Md Imtiazul, et al.
Publicado: (2022) -
Influence of Probiotics on the Development of Clostridioides difficile Infection in Patients Receiving Fluoroquinolones
por: Sheffield, Mary E., et al.
Publicado: (2021)